Francois P. Vandervegt

Array ( [id] => 296064 [patent_doc_number] => 07541334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Hybrid peptides modulate the immune response' [patent_app_type] => utility [patent_app_number] => 11/732639 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14681 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541334.pdf [firstpage_image] =>[orig_patent_app_number] => 11732639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069474 [patent_doc_number] => 20070190576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Mitogenic oxygenase regulators' [patent_app_type] => utility [patent_app_number] => 11/712222 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16782 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190576.pdf [firstpage_image] =>[orig_patent_app_number] => 11712222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120578 [patent_doc_number] => 20070142293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'METHODS OF TREATING DISEASES WITH ACTIVATED PROTEIN C' [patent_app_type] => utility [patent_app_number] => 11/678684 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7456 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142293.pdf [firstpage_image] =>[orig_patent_app_number] => 11678684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820696 [patent_doc_number] => 07408029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Peptide epitopes recognized by disease promoting CD4+ T lymphocytes' [patent_app_type] => utility [patent_app_number] => 11/670818 [patent_app_country] => US [patent_app_date] => 2007-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20013 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408029.pdf [firstpage_image] =>[orig_patent_app_number] => 11670818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820698 [patent_doc_number] => 07408031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Peptide epitopes recognized by disease promoting CD4+ T lymphocytes' [patent_app_type] => utility [patent_app_number] => 11/670830 [patent_app_country] => US [patent_app_date] => 2007-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20014 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408031.pdf [firstpage_image] =>[orig_patent_app_number] => 11670830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7692219 [patent_doc_number] => 20070231814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'DNA sequences isolated from human colonic epithelial cells' [patent_app_type] => utility [patent_app_number] => 11/603483 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44597 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231814.pdf [firstpage_image] =>[orig_patent_app_number] => 11603483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800190 [patent_doc_number] => 07425332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Treatment of autoimmune conditions with Copolymer 1 and related Copolymers' [patent_app_type] => utility [patent_app_number] => 11/528894 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17556 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425332.pdf [firstpage_image] =>[orig_patent_app_number] => 11528894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005754 [patent_doc_number] => 20070203327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces' [patent_app_type] => utility [patent_app_number] => 11/519301 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23104 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203327.pdf [firstpage_image] =>[orig_patent_app_number] => 11519301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219303 [patent_doc_number] => 20070160614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Human TIMP-1 antibodies' [patent_app_type] => utility [patent_app_number] => 11/504527 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18544 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160614.pdf [firstpage_image] =>[orig_patent_app_number] => 11504527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688921 [patent_doc_number] => 20060287236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases' [patent_app_type] => utility [patent_app_number] => 11/501582 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6963 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287236.pdf [firstpage_image] =>[orig_patent_app_number] => 11501582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921398 [patent_doc_number] => 20060240020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Inhibition of complement activation' [patent_app_type] => utility [patent_app_number] => 11/478089 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 20296 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240020.pdf [firstpage_image] =>[orig_patent_app_number] => 11478089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732303 [patent_doc_number] => 20060257420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions' [patent_app_type] => utility [patent_app_number] => 11/443314 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20768 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257420.pdf [firstpage_image] =>[orig_patent_app_number] => 11443314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860705 [patent_doc_number] => 07371845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'MAGE-A3 peptides presented by HLA class II molecules' [patent_app_type] => utility [patent_app_number] => 11/439334 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 20773 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371845.pdf [firstpage_image] =>[orig_patent_app_number] => 11439334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 54392 [patent_doc_number] => 07767791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Methods, products and treatments for diabetes' [patent_app_type] => utility [patent_app_number] => 11/413130 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 10389 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767791.pdf [firstpage_image] =>[orig_patent_app_number] => 11413130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661068 [patent_doc_number] => 20060251664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Method for the identification of epitopes related to immunogenicity in biopharmaceuticals' [patent_app_type] => utility [patent_app_number] => 11/404253 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13041 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251664.pdf [firstpage_image] =>[orig_patent_app_number] => 11404253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666604 [patent_doc_number] => 20060171954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Antigen specific activated T-lymphocytes, detection and use' [patent_app_type] => utility [patent_app_number] => 11/397759 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9645 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171954.pdf [firstpage_image] =>[orig_patent_app_number] => 11397759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759530 [patent_doc_number] => 20060210475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Humanized L243 antibodies' [patent_app_type] => utility [patent_app_number] => 11/368296 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 33841 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210475.pdf [firstpage_image] =>[orig_patent_app_number] => 11368296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655193 [patent_doc_number] => 20060140928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Use of heparinases to decrease inflammatory response' [patent_app_type] => utility [patent_app_number] => 11/357967 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17315 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140928.pdf [firstpage_image] =>[orig_patent_app_number] => 11357967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853120 [patent_doc_number] => 07378505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Assay method for group transfer reactions' [patent_app_type] => utility [patent_app_number] => 11/353500 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 26057 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378505.pdf [firstpage_image] =>[orig_patent_app_number] => 11353500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872954 [patent_doc_number] => 20060165694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/333197 [patent_app_country] => US [patent_app_date] => 2006-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 8299 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165694.pdf [firstpage_image] =>[orig_patent_app_number] => 11333197 [rel_patent_id] =>[rel_patent_doc_number] =>)